BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22290434)

  • 41. SV-40 large T antigen reversibly inhibits expression of tyrosinase, TRP-1, TRP-2 and Mitf, but not Pax-3, in conditionally immortalized mouse melanocytes.
    Prince S; Illing N; Kidson SH
    Cell Biol Int; 2001; 25(1):91-102. PubMed ID: 11237412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
    Cook AL; Sturm RA
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
    Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B
    Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.
    Koludrovic D; Laurette P; Strub T; Keime C; Le Coz M; Coassolo S; Mengus G; Larue L; Davidson I
    PLoS Genet; 2015 Oct; 11(10):e1005555. PubMed ID: 26440048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion.
    Fane ME; Chhabra Y; Spoerri L; Simmons JL; Ludwig R; Bonvin E; Goding CR; Sturm RA; Boyle GM; Haass NK; Piper M; Smith AG
    J Invest Dermatol; 2022 Jul; 142(7):1845-1857. PubMed ID: 34958806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism.
    Thomas AJ; Erickson CA
    Development; 2009 Jun; 136(11):1849-58. PubMed ID: 19403660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of PAX3 contributes to melanoma phenotypes by affecting proliferation, invasion, and transformation.
    Iyengar AS; Miller PJ; Loupe JM; Hollenbach AD
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):846-8. PubMed ID: 24903325
    [No Abstract]   [Full Text] [Related]  

  • 48. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.
    Verastegui C; Bille K; Ortonne JP; Ballotti R
    J Biol Chem; 2000 Oct; 275(40):30757-60. PubMed ID: 10938265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of PAX3 by TGF-beta modulates melanocyte viability.
    Yang G; Li Y; Nishimura EK; Xin H; Zhou A; Guo Y; Dong L; Denning MF; Nickoloff BJ; Cui R
    Mol Cell; 2008 Nov; 32(4):554-63. PubMed ID: 19026785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line.
    Zhu BK; Pruitt SC
    Melanoma Res; 2005 Oct; 15(5):363-73. PubMed ID: 16179863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcription factor MITF regulates cardiac growth and hypertrophy.
    Tshori S; Gilon D; Beeri R; Nechushtan H; Kaluzhny D; Pikarsky E; Razin E
    J Clin Invest; 2006 Oct; 116(10):2673-81. PubMed ID: 16998588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
    Denat L; Larue L
    Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pax3 functions at a nodal point in melanocyte stem cell differentiation.
    Lang D; Lu MM; Huang L; Engleka KA; Zhang M; Chu EY; Lipner S; Skoultchi A; Millar SE; Epstein JA
    Nature; 2005 Feb; 433(7028):884-7. PubMed ID: 15729346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.
    Potterf SB; Furumura M; Dunn KJ; Arnheiter H; Pavan WJ
    Hum Genet; 2000 Jul; 107(1):1-6. PubMed ID: 10982026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PAX3 across the spectrum: from melanoblast to melanoma.
    Medic S; Ziman M
    Crit Rev Biochem Mol Biol; 2009 Jun; 44(2-3):85-97. PubMed ID: 19401874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.
    Bondurand N; Pingault V; Goerich DE; Lemort N; Sock E; Le Caignec C; Wegner M; Goossens M
    Hum Mol Genet; 2000 Aug; 9(13):1907-17. PubMed ID: 10942418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MITF Drives a Reversible Drug-Tolerant State in Melanoma.
    Cancer Discov; 2016 May; 6(5):OF11. PubMed ID: 27012829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
    Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
    J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
    Kundu A; Quirit JG; Khouri MG; Firestone GL
    Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination.
    Pinner S; Jordan P; Sharrock K; Bazley L; Collinson L; Marais R; Bonvin E; Goding C; Sahai E
    Cancer Res; 2009 Oct; 69(20):7969-77. PubMed ID: 19826052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.